In addition, NCCN guidelines set up very low-risk PCa as clinical T1c, GS ≤6, PSA <10 ng/ml, number of positive core <3, tumor content per positive biopsy core ≤50%, and PSA density <0.15 ng/ml/g [17]. Here, KLK3 is linked to posterior cortical atrophy.